1. Home
  2. AMH vs UTHR Comparison

AMH vs UTHR Comparison

Compare AMH & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Homes 4 Rent of Beneficial Interest

AMH

American Homes 4 Rent of Beneficial Interest

HOLD

Current Price

$30.83

Market Cap

11.8B

Sector

Real Estate

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$489.62

Market Cap

20.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMH
UTHR
Founded
2012
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
20.3B
IPO Year
2013
1999

Fundamental Metrics

Financial Performance
Metric
AMH
UTHR
Price
$30.83
$489.62
Analyst Decision
Buy
Buy
Analyst Count
15
12
Target Price
$38.20
$495.08
AVG Volume (30 Days)
2.5M
424.3K
Earning Date
10-29-2025
10-29-2025
Dividend Yield
3.89%
N/A
EPS Growth
23.05
16.08
EPS
1.18
26.38
Revenue
$1,831,836,000.00
$3,128,400,000.00
Revenue This Year
$8.29
$13.64
Revenue Next Year
$4.11
$5.78
P/E Ratio
$26.14
$18.55
Revenue Growth
7.71
13.50
52 Week Low
$30.63
$266.98
52 Week High
$39.49
$492.62

Technical Indicators

Market Signals
Indicator
AMH
UTHR
Relative Strength Index (RSI) 34.23 68.10
Support Level $31.80 $470.13
Resistance Level $32.73 $492.62
Average True Range (ATR) 0.49 10.72
MACD -0.09 -0.53
Stochastic Oscillator 9.31 89.55

Price Performance

Historical Comparison
AMH
UTHR

About AMH American Homes 4 Rent of Beneficial Interest

American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: